Cited In for PMID: 20621999

Year	Number of Results
2010	2
2011	8
2012	6
2013	4
2014	6
2015	8
2016	5
2017	2
2018	4
2019	3
2020	2
2021	4
2022	4
2023	2
2024	1

1

MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targets.

Meyer-Rochow GY, Jackson NE, Conaglen JV, Whittle DE, Kunnimalaiyaan M, Chen H, Westin G, Sandgren J, Stålberg P, Khanafshar E, Shibru D, Duh QY, Clark OH, Kebebew E, Gill AJ, Clifton-Bligh R, Robinson BG, Benn DE, Sidhu SB. Meyer-Rochow GY, et al. Endocr Relat Cancer. 2010 Aug 16;17(3):835-46. doi: 10.1677/ERC-10-0142. Print 2010 Sep. Endocr Relat Cancer. 2010. PMID: 20621999

2

From diagnosis to resistance: a symphony of miRNAs in pheochromocytoma progression and treatment response.

Elsakka EGE, Elshafei A, Elkady MA, Yehia AM, Abulsoud AI, Shahin RK, Abdelmaksoud NM, Elkhawaga SY, Ismail A, Mokhtar MM, Elrebehy MA, Hegazy M, Elballal MS, Mohammed OA, Abdel-Reheim MA, El-Dakroury WA, Abdel Mageed SS, El-Mahdy HA, Doghish AS. Elsakka EGE, et al. Naunyn Schmiedebergs Arch Pharmacol. 2024 Apr;397(4):1957-1969. doi: 10.1007/s00210-023-02759-0. Epub 2023 Oct 6. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 37801146 Review.

3

Hypoxia signaling pathway: A central mediator in endocrine tumors.

Watts D, Jaykar MT, Bechmann N, Wielockx B. Watts D, et al. Front Endocrinol (Lausanne). 2023 Jan 9;13:1103075. doi: 10.3389/fendo.2022.1103075. eCollection 2022. Front Endocrinol (Lausanne). 2023. PMID: 36699028 Free PMC article. Review.

4

Protein Kinase D1 Signaling in Cancer Stem Cells with Epithelial-Mesenchymal Plasticity.

Guo Y, Jiang Y, Rose JB, Nagaraju GP, Jaskula-Sztul R, Hjelmeland AB, Beck AW, Chen H, Ren B. Guo Y, et al. Cells. 2022 Dec 1;11(23):3885. doi: 10.3390/cells11233885. Cells. 2022. PMID: 36497140 Free PMC article.

5

Overexpression of miR-375 and L-type Amino Acid Transporter 1 in Pheochromocytoma and Their Molecular and Functional Implications.

Manso J, Bertazza L, Barollo S, Mondin A, Censi S, Carducci S, Ferrara AM, Boschin IM, Zovato S, Schiavi F, Gregianin M, Pennelli G, Iacobone M, Mian C. Manso J, et al. Int J Mol Sci. 2022 Feb 22;23(5):2413. doi: 10.3390/ijms23052413. Int J Mol Sci. 2022. PMID: 35269556 Free PMC article.

6

The Role of the Metabolome and Non-Coding RNA on Pheochromocytomas and Paragangliomas: An Update.

Bouça B, Bogalho P, Rizzo M, Silva-Nunes J. Bouça B, et al. Metabolites. 2022 Feb 1;12(2):131. doi: 10.3390/metabo12020131. Metabolites. 2022. PMID: 35208206 Free PMC article.

7

Potential Biomarkers of Metastasizing Paragangliomas and Pheochromocytomas.

Snezhkina A, Pavlov V, Dmitriev A, Melnikova N, Kudryavtseva A. Snezhkina A, et al. Life (Basel). 2021 Nov 4;11(11):1179. doi: 10.3390/life11111179. Life (Basel). 2021. PMID: 34833055 Free PMC article. Review.

8

A Critical Appraisal of Contemporary and Novel Biomarkers in Pheochromocytomas and Adrenocortical Tumors.

Tsoli M, Daskalakis K, Kassi E, Kaltsas G, Tsolakis AV. Tsoli M, et al. Biology (Basel). 2021 Jun 25;10(7):580. doi: 10.3390/biology10070580. Biology (Basel). 2021. PMID: 34201922 Free PMC article. Review.

9

Essential Role of the 14q32 Encoded miRNAs in Endocrine Tumors.

Krokker L, Patócs A, Butz H. Krokker L, et al. Genes (Basel). 2021 May 8;12(5):698. doi: 10.3390/genes12050698. Genes (Basel). 2021. PMID: 34066712 Free PMC article. Review.

10

MicroRNAs, Long Non-Coding RNAs, and Circular RNAs: Potential Biomarkers and Therapeutic Targets in Pheochromocytoma/Paraganglioma.

Turai PI, Nyírő G, Butz H, Patócs A, Igaz P. Turai PI, et al. Cancers (Basel). 2021 Mar 26;13(7):1522. doi: 10.3390/cancers13071522. Cancers (Basel). 2021. PMID: 33810219 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

49 results

Results by year